Oxford Finance LLC logo

Oxford Finance LLC

North America, Virginia, United States, Alexandria

Description

Oxford Finance LLC is a prominent specialty finance firm based in Alexandria, Virginia, dedicated to providing senior secured debt capital to healthcare and life sciences companies. Unlike traditional venture capital firms that focus on equity investments, Oxford Finance offers flexible debt solutions, including term loans, revolving lines of credit, and venture debt, tailored to the unique needs of companies ranging from clinical-stage biotechs to commercial-stage medical device and healthcare service providers. Their expertise lies in understanding the complex regulatory and commercial landscapes of these sectors, enabling them to structure financing that supports product development, commercialization, and general corporate purposes without significant equity dilution.

With a robust track record, Oxford Finance has established itself as a significant capital provider in the life sciences and healthcare ecosystem. The firm has deployed over $12 billion in capital since its inception, demonstrating its long-standing commitment and capacity to support innovation and growth within these critical industries. This substantial capital deployment highlights their deep industry relationships and ability to execute complex financing arrangements for a diverse portfolio of companies. Their strategic approach often involves partnering with venture capital and private equity firms, complementing equity rounds with debt financing.

Oxford Finance typically provides loan facilities ranging from $5 million to $150 million, catering to a broad spectrum of company sizes and stages within their target sectors. Their financing solutions are designed to be non-dilutive, offering an attractive alternative or complement to equity funding for companies seeking to extend their cash runway, fund clinical trials, or scale commercial operations. In 2023 alone, Oxford Finance committed over $2.5 billion in new debt facilities, underscoring their active role and continued expansion in the market. Their due diligence process is rigorous, focusing on intellectual property, management teams, and market potential to ensure the viability of their portfolio companies.

Investor Profile

Oxford Finance LLC has backed more than 155 startups, with 3 new investments in the last 12 months alone. The firm has led 70 rounds, about 45% of its total and boasts 91 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Debt Financing, Post Ipo Debt, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, Ireland.
  • Strong thematic focus on Health Care, Biotechnology, Medical.
  • Led 3 rounds in the past year.
  • Typical check size: $5M – $150M.

Stage Focus

  • Debt Financing (54%)
  • Post Ipo Debt (37%)
  • Series Unknown (4%)
  • Series B (2%)
  • Post Ipo Equity (1%)
  • Series E (1%)
  • Series C (1%)
  • Series A (1%)

Country Focus

  • United States (92%)
  • United Kingdom (4%)
  • Ireland (1%)
  • Canada (1%)
  • The Netherlands (1%)
  • Switzerland (1%)
  • Germany (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Pharmaceutical
  • Therapeutics
  • Health Diagnostics
  • Biopharma
  • Life Science
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Oxford Finance LLC frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 2
Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
East West Bank
North America, California, United States, Pasadena
Co-Investments: 3
Square 1 Bank
North America, North Carolina, United States, Durham
Co-Investments: 4
GE Capital
North America, Ontario, Canada, Ottawa
Co-Investments: 2
Scale Venture Partners
North America, California, United States, Foster City
Co-Investments: 2
Silicon Valley Bank
North America, California, United States, Santa Clara
Co-Investments: 46
Armentum Partners
North America, California, United States, San Francisco
Co-Investments: 3
Clarus Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
MidCap Financial
North America, Maryland, United States, Bethesda
Co-Investments: 4

What are some of recent deals done by Oxford Finance LLC?

Vera Therapeutics

South San Francisco, California, United States

Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.

BiotechnologyHealth Care
Post Ipo DebtJun 3, 2025
Amount Raised: $75,000,000
Inhibrx

La Jolla, California, United States

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

BiotechnologyLife ScienceTherapeutics
Post Ipo DebtJan 13, 2025
Amount Raised: $150,000,000
Soleno Therapeutics

Redwood City, California, United States

Soleno Therapeutics is a clinical-stage biopharmaceutical company.

BiotechnologyMedicalPharmaceutical
Post Ipo DebtDec 17, 2024
Amount Raised: $50,000,000
Verona Pharma

London, England, United Kingdom

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.

BiotechnologyPharmaceuticalTherapeutics
Post Ipo DebtJan 2, 2024
Amount Raised: $400,000,000
Headspace

Santa Monica, California, United States

Headspace specializes in providing mental healthcare, including coaching therapy and psychiatry, as well as meditation mindfulness tools.

FitnessHealth CareInternetMedicalMental HealthmHealthMobile AppsTherapeutics
Debt FinancingJul 26, 2023
Amount Raised: $105,000,000
Amino

San Francisco, California, United States

Amino is a data-driven healthcare guidance platform that helps companies and their employees navigate the complex US healthcare system.

Employee BenefitsFinancial ServicesHealth CareWellness
Debt FinancingMay 11, 2023
Amount Raised: $42,000,000
Pearl Street Dental Management

Dallas, Texas, United States

Pearl Street Dental provides succession plans for retiring dentists and supports non-clinical operations.

FinanceHuman ResourcesManagement Consulting
Debt FinancingNov 16, 2022
Amount Raised: $115,000,000
Renibus Therapeutics

Southlake, Texas, United States

Renibus Therapeutics is a clinical-stage biotech company that focuses on preventing and treating kidney disease.

BiotechnologyHealth CareTherapeutics
Debt FinancingNov 14, 2022
Amount Raised: $10,000,000
ALX Oncology

San Francisco, California, United States

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

BiopharmaBiotechnologyHealth CareLife ScienceOncologyTherapeutics
Post Ipo DebtOct 31, 2022
Amount Raised: $100,000,000
Verona Pharma

London, England, United Kingdom

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.

BiotechnologyPharmaceuticalTherapeutics
Post Ipo DebtOct 17, 2022
Amount Raised: $150,000,000